Medical Properties Trust (MPW) Insider Grant: Time-Vested and TSR Awards
Rhea-AI Filing Summary
Insider grant and ownership change at Medical Properties Trust (MPW). Larry H. Portal, SVP and Senior Advisor to the CEO, was reported as acquiring two equity awards on 09/24/2025. One grant of 59,743 common shares vests quarterly through March 31, 2028 and increased his beneficial ownership to 463,589 shares. A second performance-based grant of 25,058 shares is contingent on three-year total shareholder return (TSR) hurdles through April 14, 2028 (20% TSR = 100% payout; 40% = 200%; 60% = 300%); if earned, those shares vest in equal quarterly installments over the following year or in full upon final Compensation Committee determination, subject to continued employment. The Form 4 was filed 09/26/2025 and signed by a power of attorney.
Positive
- Management-shareholder alignment through time-based and TSR-linked equity awards
- Transparent performance hurdles (20%/40%/60% TSR mapped to 100%/200%/300% payouts) with linear interpolation
- Retention-focused vesting with quarterly vesting through March 31, 2028 and post-performance quarterly vesting
Negative
- Performance tranche is contingent on achieving specified TSR hurdles through April 14, 2028, so upside is not guaranteed
- Filing lacks grant-date valuation, so investors cannot assess compensation cost or dilution from this form alone
- Continued employment requirement may limit liquidity and immediate alignment if the executive departs
Insights
TL;DR Routine executive equity grants align management with shareholders but include multi-year performance and vesting conditions.
The awards combine time-based and performance-based equity, a common design to retain senior executives and link pay to shareholder outcomes. The time-vested tranche vests quarterly through March 2028 providing steady alignment. The performance tranche ties payout to explicit TSR hurdles over a three-year period, with escalation from 100% to 300% based on 20%–60% TSR outcomes. The structure preserves accountability via continued employment requirements and final Compensation Committee determination. This disclosure appears standard and informational rather than transformational for investors.
TL;DR Mix of quarterly time vesting and aggressive TSR-based upside; materiality is moderate given the award sizes versus total holdings.
The time-based award of 59,743 shares and the potential 25,058 performance shares increase reported beneficial ownership to 488,647 if performance shares are earned. The performance metrics use clear TSR hurdles with linear interpolation between levels, which creates transparent payout mechanics. Vesting schedules extend to 2028, emphasizing retention. The filing does not disclose grant-date fair value or proportion of annual equity opportunity, so absolute compensation impact cannot be determined from this form alone.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common stock, par value $0.001 | 59,743 | $0.00 | -- |
| Grant/Award | Common stock, par value $0.001 | 25,058 | $0.00 | -- |
Footnotes (1)
- Shares vest at the beginning of each calendar quarter ending March 31, 2028. The shares were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period ending April 14, 2028 as follows: (i) if the Company's TSR reaches 20%, 100% of the shares will be earned; (ii) if the Company's TSR reaches 40%, 200% of the shares will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 3). Earned shares will become vested in equal quarterly installments over one year following the date the shares are earned, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.
